Frontlight ResearchEarly access
Trial site
Subei People's Hospital of Jiangsu province
- 8running trials
- 6closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer3 trials
- COPD2 trials
- Haemophilia2 trials
- Lung cancer2 trials
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Metastatic breast cancer1 trial
- Migraine1 trial
- Phase
- Phase 310 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3 trials
- Hangzhou Gensciences Biopharmaceutical Co., Ltd.2 trials
- Hoffmann-La Roche2 trials
- Jiangsu HengRui Medicine Co., Ltd.1 trial
- Nanjing Medical University1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment
Recruiting
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD2 recruiting
- Coronary artery disease1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Completed
Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein
Completed
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026